Sinusitis in HIV: microbiology and therapy.
Rhinosinusitis in the HIV-infected population is an increasingly common finding as HIV infection has transitioned toward becoming a chronic medical condition. In this patient population, rhinosinusitis may be challenging to diagnose and treat effectively. However, adequate diagnostic tools are available, microbial identity can be reasonably anticipated based on the CD4 count, and effective management strategies can be implemented. In this article, we discuss the diagnostic and therapeutic options for HIV-infected patients with rhinosinusitis.
Shah
Ashish R
AR
Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati, 231 Albert Sabin Way, PO Box 670528, Cincinnati, OH 45267, USA.
Hairston
Jahmal A
JA
Tami
Thomas A
TA
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002908:Chronic Disease; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D015658:HIV Infections / Q000150:complications* / Q000276:immunology; D006801:Humans; D012852:Sinusitis / Q000188:drug therapy* / Q000209:etiology* / Q000382:microbiology
D000900:Anti-Bacterial Agents